Clare Terlouw

Clare Terlouw is a prominent figure in the life sciences and healthcare investment sector. She currently serves as the Head of LifeArc Ventures and holds a position as Director on the Board of Closed Loop Medicine.12

Professional Background

Clare Terlouw has an extensive background in biotech and healthcare financing:

• She has 15 years of experience as an investment banker in the City of London, specializing in growth funding for healthcare companies.3
• Prior to her current role, she was the head of corporate development at Syncona, a leading healthcare investment company.4

Current Roles

Head of LifeArc Ventures: As the Head of LifeArc Ventures, Clare is responsible for:

• Managing LifeArc's portfolio of direct and LP investments across the life sciences sector.5
• Leading the Early Ventures team at LifeArc.1

Director at Closed Loop Medicine: Clare joined the Board of Closed Loop Medicine as part of a £13 million financing round in 2021.1 In this role, she contributes her expertise to guide the company's development of drug plus digital therapy (DTx) combination products.

Impact and Expertise

Clare Terlouw is recognized for her:

• Significant expertise in growth funding for healthcare companies.3
• Leadership in building an investment platform focused on early-stage biopharma.4
• Involvement in supporting innovative healthcare solutions, such as Closed Loop Medicine's precision dosing products.1

Her appointment to the Closed Loop Medicine Board was seen as bringing valuable experience and insight to the company as it works on improving patient outcomes through personalized medicine approaches.1